Home

arrow iconNewsarrow iconarrow icon

Time-Lapse Images of IVF Embryos with ARMS Embryo Watch to Empower Patients with Real-Time Development Tracking

Time-Lapse Images of IVF Embryos with ARMS Embryo Watch to Empower Patients with Real-Time Development Tracking

ARMS Embryo Watch offers time-lapse images of IVF embryos to patients by streaming each development stage and showing the output directly to the patient's device, enhancing transparency and emotional connection throughout the IVF journey.

By FertilityIn

09 Apr 2026

3 min read

 Time-lapse images of IVF embryos

Time-lapse images of IVF embryos

ARMS Embryo Watch lets patients see time-lapse images of IVF embryos as they grow. It streams each stage of development, from fertilization to implantation, directly to the patient's device (smartphone or computer). The embryologist uses integrated AI software to look at these pictures and put the information into clear, easy-to-read reports.


What is Embryo Watch embryo development monitoring?

In Arizona, ARMS Embryo Watch is the first of its kind to use CHLOE technology. It gives patients a private, safe time-lapse images of IVF embryos as they grow in real time through a secure link. There are two cutting-edge technologies that make up Embryo Watch. The first is a system for monitoring an embryo incubator over time. The second commandment is its AI software.


These things together make the IVF patient's experience better and could improve the results of IVF. There are still studies going on, and they look pretty promising.


Key features of Embryo Watch

  • Visual progress tracking - You can see time-lapse videos and easy-to-read reports on your phone or computer that show how your embryos grow during in vitro fertilization - IVF lab incubation.
  • Real-time collaborative viewing - Patients and embryologists can both watch the growth of embryos as it happens in a secure way.
  • Possibility of making the IVF embryo environment better - The hardest part of growing embryos in vitro is keeping the environment as close to the womb as possible. One might be able to do that with the help of Embryo Watch.


Advantages of time-lapse incubator embryo monitoring as opposed to standard incubator monitoring

ARMS Embryo Watch is a leader in the use of new technologies in fertility care. This program uses time-lapse incubator monitoring and specialised software to improve the patient's experience and possibly their embryos' growth.


Better prediction of how embryos will grow

A 2024 study found that this cultural method made it more likely that the first embryo transfer would result in a live birth. Internal data from CHLOE showed that the ongoing pregnancy rate with the CHLOE system was 48.5%, while the ongoing pregnancy rate with traditional methods for the first embryo transfer was only 33.5%. This meant that it took less time to get pregnant 1.77 transfers instead of 2.19 transfers with traditional methods.


Continuous monitoring fills in embryologists' knowledge gaps about how embryos grow

Time-lapse incubator technology is a big step forward from regular IVF monitoring for embryos. Traditional IVF labs only examine embryos at specific intervals, such as Day 1 and Days 5–7. This is called a snapshot approach. Sporadic monitoring may result in missing crucial developmental events that indicate the health and potential of an embryo. This can change how you look at the best embryos, which can alter the chances of getting pregnant after implantation.


Keeps the embryo environment just right

ARMS takes many steps to keep embryos safe when they are not in the incubator, which is why there are such high pregnancy rates. Time-lapse monitoring adds to this protection by letting embryos stay in the incubator without being disturbed from egg retrieval to the end of the culture period before implantation. This way, every stage of development is recorded without any sort of interruption.

66 views

Share

FertilityIn

Send Enquiry for this Story

Related Articles

 Legacy Earns New York State CLEP Approval for Its DNA Fragmentation Test and Semen Analysis

Legacy Earns New York State CLEP Approval for Its DNA Fragmentation Test and Semen Analysis

Legacy, North America's leading digital male fertility clinic, has secured New York State CLEP approval for both its semen analysis and DNA fragmentation test – the only mandatory pre-market laboratory review programme in the United States. The approvals confirm clinical-grade validity for at-home samples, extending access to New York patients without a clinic visit.

ART

1 min read

South Australia's Fertility Treatment Rebate Scheme Launches

South Australia's Fertility Treatment Rebate Scheme Launches

From 1 July 2026, South Australia's Fertility Treatment Rebate Scheme provides eligible residents with a $250 rebate for pre-treatment testing and a $2,000 rebate for up to two fertility treatment cycles. Backed by an $18.5 million, four-year government commitment, the scheme directly addresses the financial barriers preventing South Australians from accessing fertility care.

ART

1 min read

Sapyen Partners with My Surrogacy Journey to Enhance Fertility Testing and Reproductive Health Services Across the U.S.

Sapyen Partners with My Surrogacy Journey to Enhance Fertility Testing and Reproductive Health Services Across the U.S.

apyen, a global leader in male fertility diagnostics, has entered a strategic partnership with My Surrogacy Journey to broaden fertility testing and reproductive health support for intended parents across the United States. The collaboration covers semen analysis, DNA fragmentation testing, and infectious disease screening, with plans for international expansion.

ART

1 min read

Fertility Institute of Hawaii Joins Nucleus IVF+ Network as Genetic Optimization Demand Expands

Fertility Institute of Hawaii Joins Nucleus IVF+ Network as Genetic Optimization Demand Expands

Nucleus Genomics has announced that the Fertility Institute of Hawaii Joins Nucleus IVF+ network, bringing advanced carrier and embryo screening to Hawaii's largest IVF practice. The partnership expands genetic optimization access across the Pacific, with risk reduction data covering endometriosis, heart disease, breast cancer, type 1 diabetes, and Alzheimer's disease.

ART

1 min read

Taiwan Pioneers AI-Powered Embryo Selection Model, Improving Chromosomally Normal Embryo Identification Rate by Up to 24%

Taiwan Pioneers AI-Powered Embryo Selection Model, Improving Chromosomally Normal Embryo Identification Rate by Up to 24%

TFC Taipei Fertility Center has introduced an AI-Powered Embryo Selection model that improves chromosomally normal embryo identification by up to 24%. Presented at ASPIRE 2026, the iDAScore v2.0 system brings precision and objectivity to IVF treatment, reducing implantation failure risk and shortening time to conception for infertile patients.

ART

1 min read

CDT Equity Completes Global Patent Coverage for AZD5904 in Male Infertility Following Canadian Grant

CDT Equity Completes Global Patent Coverage for AZD5904 in Male Infertility Following Canadian Grant

CDT Equity Inc. (Nasdaq: CDT) has announced the Canadian patent grant for AZD5904 in male infertility, completing approval across all key pharmaceutical target markets. The milestone strengthens CDT's IP position for the AstraZeneca-licensed Myeloperoxidase inhibitor as the company advances active out-licensing and strategic partnering discussions for the asset.

ART

1 min read

Nucleus IVF+ Joins SCRC to Bring Genetic Optimization to One of America's Most In-Demand Fertility Centers

Nucleus IVF+ Joins SCRC to Bring Genetic Optimization to One of America's Most In-Demand Fertility Centers

Nucleus Genomics has announced that Nucleus IVF+ joins SCRC, the Southern California Reproductive Center, as part of its rapidly expanding global network. The partnership integrates advanced carrier screening and embryo analysis across SCRC's four California locations, serving thousands of patients annually across Beverly Hills, Santa Barbara, Pasadena, and Ventura.

ART

1 min read

Landing Page Image

Subscribe to our Newsletter

Stay updated with the latest news, expert insights, and exclusive offers delivered straight to your inbox. Join our community today!

Email Address